In this week’s podcast: We ask how health research can be regulated in a way that protects patients without stifling science and we hear from a group of Californians who have come to learn about bioscience in Britain.
Studio guest is David Gillen, head of international medical affairs at Gilead Sciences.
Also on the show: Moira Gunn, head of biotechnology programmes at the University of San Francisco business school and two of her masters degree students, Olga Levin and Karim Michael Tahir.
Presented by Clive Cookson, with Diana Garnham.
Produced by LJ Filotrani